ACAD


Acadia Rises 21.8% on Positive Lavender Study Results

This article was originally published on TipRanks.com Shares of Acadia Pharmaceuticals Inc.

FDA Rejects Acadia’s Supplemental New Drug Application For NUPLAZID; Shares Plunge

Shares of Acadia Pharmaceuticals plunged more than 15% in early trade on Monday after the biopharmaceutical company received a Complete Response Letter (CRL) …

Acadia Plunges 12% As Depressive Study Misses Goals; Analyst Says Buy

Shares in Acadia Pharmaceuticals (ACAD) plunged 12% in Monday’s extended trading, after the company announced disappointing top-line results from its 298 patient Phase …

Acadia Files Nuplazid Label Expansion; Analyst Sees ‘Significant’ Potential

Acadia Pharmaceuticals Inc. (ACAD) has announced that it has filed a supplemental New Drug Application (sNDA) to the U.

Top Analyst Stands Firm for Acadia Pharmaceutical (ACAD) Stock While its Anti-Depression Medication Goes Through Trial

After a series of talks with depression key opinion leaders (KOL) about Acadia Pharmaceutical’s (ACAD) Ph2 CLARITY trial, all four experts believe the …

Acadia Pharmaceuticals (ACAD): Another Glimpse Into Nuplazid Safety Profile

Acadia Pharmaceuticals (NASDAQ:ACAD) is a biopharmaceutical company based in San Diego and focused on the development of therapeutics to treat central nervous system …

ACADIA Pharmaceuticals (ACAD): Top Analyst Does Not See ‘Real Safety Signal’ for Nuplazid

Cowen’s Ritu Baral’s conversations with key experts in the field with Nuplazid experience leave her positive; albeit somewhat ‘cautious’ on the impact of ACAD’s controversy.

Here’s Why ACADIA Pharmaceuticals Stock Is Plummeting 25% Today

ACADIA Pharmaceuticals (NASDAQ:ACAD) just got hit with a bad bullet: a CNN research report questioning lead asset Nuplazid’s risk/reward as a treatment of …

Here’s Why ACADIA Pharmaceuticals Inc. (ACAD) Shares Are Diving Today

Has Wall Street gone a bit overboard punishing ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)?

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts